Biologists in Nice propose three roles in the spread of aging between organs, initiator, transmitter, and effector, and identify an experiment that could disprove their model
Biologists in Nice propose three roles in the spread of aging between organs, initiator, transmitter, and effector, and identify an experiment that could disprove their model
In a paper published on 12 November in Philosophical Transactions B, Miguel Godinho Ferreira’s group proposed an explanation for why the whole body ages together when damage begins in one organ. Each component’s role in the chain is defined by the outcome of an intervention targeting it.
The authors argue that the causal relationships between the “hallmarks of aging,” such as shortening of telomeres (the protective ends of chromosomes) and mitochondrial dysfunction, remain unclear. They propose three roles to address this gap. An initiator is damage within one organ: repairing it only in that organ improves function in distant organs, while inducing it only there worsens their function. A transmitter is a communication pathway: interrupting it makes dysfunction in distant organs independent of the original damage, even though that damage persists. An effector is a state in a recipient organ, such as stem cell exhaustion or mitochondrial dysfunction, that develops without enough damage within that organ to account for it.
Each role is specific to a “source organ → recipient organ” pair, which the authors call an axis. In their model, mitochondrial dysfunction is an initiator in muscle and fat, and an effector in organs reached by the inflammatory signal. The authors depict the network of connections between organs as a tree: initiators in many organs converge on a trunk consisting of a few transmitters (inflammation, hormones), from which effectors branch out.
One example of an initiator is telomere shortening in the gut of zebrafish that lack telomerase, the enzyme that extends telomeres. These fish age prematurely. According to Godinho Ferreira, the group initially looked for defects in fin regeneration, found none, and began tracking the order in which organs failed. The gut failed first. In 2023, telomerase was activated only in gut cells: the condition of the gonads and hematopoietic tissue improved, and average lifespan increased from 17 to 24 months, although telomeres in those organs remained short. The authors concluded that signals from the gut largely determined the condition of these organs.
One example of a transmitter along this axis is STING, a protein that activates inflammation when a cell detects DNA in its cytoplasm. The group had previously found inflammation throughout the bodies of these fish. In a 2025 study, they tested whether STING triggered that inflammation. Fish lacking both telomerase and STING lived an average of 24 months instead of 17, matching the result of the gut experiment. Inflammation decreased, while telomeres remained short.
The same approach did not work in mice: in a paper published in Cell Reports on 6 August, deleting STING neither extended lifespan nor protected the gut in two mouse lines lacking telomerase. The model’s authors counter that whole-body deletion also removes STING where it protects the organism, making its harmful and protective contributions impossible to separate.
“The discriminating test therefore requires interrupting the pathway in a single organ, rather than throughout the body. This has yet to be tested in mammals.”
The authors derive two approaches to slowing aging from their model: repairing the initial damage and interrupting chronic harmful communication between organs. They propose weakening this communication while preserving STING’s protective functions by enhancing enzymes such as TREX1, which degrade DNA in the cytoplasm.
The model predicts that repairing the source protects several recipient organs at once, whereas repairing a recipient organ does not. The authors themselves identify an experiment that could disprove it: restoring telomerase in fish lacking the enzyme, but only in the gonads or hematopoietic tissue, which benefited from the gut experiment. If the benefit were the same, it would disprove the model’s trunk, leaving “no other axis to fall back on.”